Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. (Q43228834)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 November 2009
edit
Language Label Description Also known as
English
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
scientific article published on 18 November 2009

    Statements

    Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. (English)
    Susanne Saussele
    Dietrich W Beelen
    Donald Bunjes
    Rainer Schwerdtfeger
    Hans-Jochem Kolb
    Anthony D Ho
    Christiane Falge
    Ernst Holler
    Günter Schlimok
    Axel R Zander
    Renate Arnold
    Lothar Kanz
    Robert Dengler
    Brigitte Schlegelberger
    Markus Pfirrmann
    Martin C Müller
    Armin Leitner
    Nadine Pletsch
    Joerg Hasford
    Rüdiger Hehlmann
    German CML Study Group
    18 November 2009
    1880-1885

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit